A Phase 3 interventional study of acetaminophen in Delirium, sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre. Recruiting at 2 sites in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-28.
Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre · Phase 3, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 80 studies in Delirium with a site in Canada — 16 open to participants now, 24 under way, 2 of them phase 3. Delirium · Canada.
Among the 80 studies in Delirium with a site in Canada, this one is the 7th largest by planned enrollment of the 53 interventional ones that give a count, is one of 4 that started in 2023, is one of 7 in phase 3, reaches primary completion later than 4 of the 23 other live ones, and was the 65th registered.
934 studies on the registry are indexed under Delirium; 188 are open to participants now.
Browse Delirium studies →16 of the 80 studies in Delirium with a site in Canada are open now. Recruiting first, the newest first:
University of Calgary · Sites in Canada
Ages up to 18
Queen's University · Sites in Canada
Ages 18+ · Healthy volunteers
Mount Sinai Hospital, Canada · Sites in Canada, United States
Ages 60+
Ciusss de L'Est de l'Île de Montréal · Sites in Canada
Ages 18+
Sunnybrook Health Sciences Centre · Sites in Canada
Ages 60+
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 124 Delirium studies recruiting now, 96 (77%) set no upper age limit and 8 (6%) stop at 75 or younger; 8 take children under 18; 14 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
80 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 7 · Phase 3 7 · Phase 4 5
First in 2003; this study’s year is marked. 4 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 900 is above the median of 111 across 551 interventional studies indexed under Delirium.
Median enrollment 88 across the 53 interventional studies, 130 across the 27 observational. Of the 42 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 80 have an industry lead sponsor. The 10 most frequent:
McGill University Health Centre/Research Institute of the McGill University Health Centre is the lead sponsor of 422 studies on the registry; 106 are open to participants now.
McGill University Health Centre/Research Institute of the McGill University Health Centre has 2 studies filed under Delirium — fewer than ten, so there is no comparison to draw.
7 of the studies in Delirium with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07051096University of British ColumbiaResponsive Nature-Driven Imagery to Reduce Delirium After Cardiac Surgery | 2026-12 |
| NCT07562048University of CalgaryTherapeutic Cuddling in Critically Ill Children | 2026-12 |
| NCT05713877Ciusss de L'Est de l'Île de MontréalMelatonin for Treatment of Delirium in Critically Ill Adult Patients | 2026-12-30 |
| NCT06027788Icahn School of Medicine at Mount SinaiCTSN Embolic Protection Trial | 2027-04-01 |
| NCT06648681University of British ColumbiaLemborexant to Prevent Post-operative Delirium in Cardiac Surgery Patients | 2027-04-30 |
Add all 7 to your calendar (.ics) → With an account.
Among the 80 studies in Delirium with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Double blind double dummy of Intravenous Acetaminophen and oral acetaminophen placebo versus IV placebo versus oral acetaminophen in patients following cardiac surgery. The primary endpoint is development of Delirium during the post-operative stay.
The study is randomized, double-blinded, and multicentre. Enrollment includes patients 18 years or older who are going for aortocoronary bypass surgery, single valve, or bypass and single valve. The intervention is blinded IV acetaminophen and blinded oral active or placebo acetaminophen . The study will start with a pilot trial of 120 patients at 4 centers- 30 at each site, 15 per group. The pilot is a vanguard. If the pilot shows appropriate compliance with the protocol, reliable blinding and appropriate enrolment, the results will not be unblinded but rolled into the full study. Stratification will be by site and age \< 60 or >= 60.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Refusal by surgeon for inclusion of the patient
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
How quickly the kidneys clear creatinine, a waste product, from the blood. A study may estimate it from a blood test with age, weight and sex (often by the Cockcroft–Gault formula), or measure it using blood and urine collected over a set time. Given in mL/min; higher is better.
Creatinine clearance (CrCl)
How quickly the kidneys clear creatinine, a waste product, from the blood. A study may estimate it from a blood test with age, weight and sex (often by the Cockcroft–Gault formula), or measure it using blood and urine collected over a set time. Given in mL/min; higher is better.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
subjects will receive IV acetaminophen and a placebo oral acetaminophen starting immediately after surgery and for 8 doses
Drug: acetaminophen
subjects will receive a placebo for IV acetaminophen and active oral acetaminophen starting immediately after surgery and for 8 doses
Drug: acetaminophen
we will use IV acetaminophen and an oral placebo or IV placebo and active oral acetaminophen
Also known as: placebo
Development of delirium post operatively
Incidence of delirium will be analyzed between patients treated with IV or oral acetaminophen, measured from 24 hours post-operation and daily until discharge. Delirium will be defined as an acute change in pre-operative baseline condition with additional features of inattention and either disorganized thinking and altered loss of consciousness, as defined by the Confusion Assessment Method (CAM) or CAMICU when in the intensive care unit
Time frame: up to 7 days post operatively
total opioid usage
tabulation of all opioids normalized to morphine
Time frame: up to 7 days post-operatively
Numeric pain rating scale
visual pain score from 1 to 10
Time frame: up to 48 hours
cognitive function
change in cognitive function score by 2 based on the Montreal cognitive assessment
Time frame: 7 days post-operative, 6 months and 1 year
hospital length of stay
Days until discharge
Time frame: length of stay is measured from the day of surgery until the day of discharge from hospital in days
Intensive care length of stay
hours in ICU
Time frame: ICU stay is measured from the hour of arrival in the ICU and until the patient leaves the ICU in hours
Started Jun 2023 (actual). Primary completion is estimated for Sep 2024, 15 months after the start.
Of 27 phase 3 interventional studies under Delirium, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 28 and three quarters within 59. This study's planned 15 months is below that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Acetaminophen
McGill University Health Centre/Research Institute of the McGill University Health Centre →